Trial Profile
Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 19 Mar 2015
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Mar 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 06 Feb 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 06 Feb 2013 Planned initiation date (May 2013) added as reported by ClinicalTrials.gov.